{
  "pmcid": "11432297",
  "sha256": "ae71e419fc603b90bfe74f0de54f00e36339389a9879b0fc069f6b024ba4c963",
  "timestamp_utc": "2025-11-09T23:16:12.224760+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.600925373134327,
    "reading_ease": 14.248179104477657,
    "word_count": 268
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Impact of Vitamin Supplementation on Cardiovascular Health"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Sample size calculation was based on detecting a significant difference in cardiovascular events."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults with cardiovascular risk factors."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received a combination of hydrophilic and lipophilic vitamins, while the control group received a placebo."
      },
      "Objective": {
        "score": 1,
        "evidence": "To assess the efficacy of vitamin supplementation in reducing the incidence of CVD."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of cardiovascular events over a 12-month period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was maintained for participants, clinicians, and outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were recruited and randomised, with 100 assigned to the intervention group and 100 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group experienced a significant reduction in cardiovascular events (mean difference = 5.2 events, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the intervention group and 1% in the control group experiencing gastrointestinal side-effects."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was funded by [source of funding]."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}